{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:17:56Z","timestamp":1765545476325},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.mcna.2007.06.010","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T17:04:10Z","timestamp":1195059850000},"page":"1151-1168","source":"Crossref","is-referenced-by-count":22,"title":["Obesity and the Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"91","author":[{"given":"Michael","family":"Magnotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2007.06.010_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.mcna.2007.06.010_bib3","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.85.7.2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib5","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of\u00a0the polycystic ovary syndrome in overweight and obese women","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)61182-0","article-title":"Effects of lifestyle modification in polycystic ovarian syndrome","volume":"12","author":"Moran","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.mcna.2007.06.010_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jc.85.1.139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00003081-200306000-00011","article-title":"Insulin sensitizers for polycystic ovary syndrome","volume":"46","author":"Baillargeon","year":"2003","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.mcna.2007.06.010_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0277-9536(01)00034-X","article-title":"\u201cThe thief of womanhood\u201d: women's experience of polycystic ovarian syndrome","volume":"54","author":"Kitzinger","year":"2002","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib11","series-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","first-page":"377","article-title":"Polycystic ovary syndrome","author":"Zawadsky","year":"1992"},{"key":"10.1016\/j.mcna.2007.06.010_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mcna.2007.06.010_bib13","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(01)00979-2","article-title":"Polycystic ovaries in hirsute women with normal menses","volume":"111","author":"Carmina","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mcna.2007.06.010_bib17","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib18","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1073\/pnas.0602025103","article-title":"Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome","volume":"103","author":"Sam","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mcna.2007.06.010_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mcna.2007.06.010_bib20","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1210\/jc.2005-0622","article-title":"Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2","volume":"90","author":"Urbanek","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jc.86.1.446","article-title":"Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus","volume":"86","author":"Tucci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib22","series-title":"Androgenic disorders","first-page":"77","article-title":"Pathophysiology of polycystic ovarian syndrome","author":"Futterweit","year":"1995"},{"key":"10.1016\/j.mcna.2007.06.010_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries: a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.06.010_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","article-title":"Polycystic ovaries and associated clinical and biochemical features in young women","volume":"51","author":"Michelmore","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mcna.2007.06.010_bib25","series-title":"Androgen excess disorders in women: polycystic ovary syndrome and other disorders","first-page":"155","article-title":"Clinical features of the polycystic ovary syndrome","author":"Futterweit","year":"2006"},{"key":"10.1016\/j.mcna.2007.06.010_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib27","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mcna.2007.06.010_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiology.163.1.3547491","article-title":"Polycystic ovarian disease: US features in 104 patients","volume":"163","author":"Yeh","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.mcna.2007.06.010_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mcna.2007.06.010_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1749-6632.2000.tb06230.x","article-title":"The genetics of obesity: lessons for polycystic ovary syndrome","volume":"900","author":"Legro","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mcna.2007.06.010_bib31","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mcna.2007.06.010_bib32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2007.06.010_bib33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mcna.2007.06.010_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.mcna.2007.06.010_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambeneri","year":"2002","journal-title":"Int J\u00a0Obes Relat Metab Disord"},{"key":"10.1016\/j.mcna.2007.06.010_bib36","series-title":"Obesity: new directions in assessment and management","first-page":"96","article-title":"An endocrine approach to obesity","author":"Futterweit","year":"1994"},{"key":"10.1016\/j.mcna.2007.06.010_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mcna.2007.06.010_bib38","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jc.82.2.556","article-title":"17 alpha-hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2007.06.010_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","article-title":"Free fatty acids in obesity and type 2 diabetes defining their role in the development of insulin resistance and b-cell dysfunction","volume":"32","author":"Boden","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mcna.2007.06.010_bib41","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Vildirim","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mcna.2007.06.010_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diabetes.45.5.633","article-title":"Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of IDDM","volume":"45","author":"Carey","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2007.06.010_bib43","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.24.5.925","article-title":"Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women","volume":"24","author":"DeNino","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2007.06.010_bib44","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","article-title":"Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance","volume":"90","author":"Puder","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","article-title":"Acanthosis nigricans associated with insulin resistance: pathophysiology and management","volume":"5","author":"Hermanns-Le","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.mcna.2007.06.010_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1210\/jcem-73-3-590","article-title":"Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological and biochemical findings","volume":"73","author":"Dunaif","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of the metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.mcna.2007.06.010_bib48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increased androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib49","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.mcna.2007.06.010_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4158\/EP.11.2.125","article-title":"American association of clinical endocrinologists position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome. Polycystic Ovary Writing Committee","volume":"11","author":"Cobin","year":"2005","journal-title":"Endocr Pract"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2007.06.010_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4158\/EP.9.S2.86","article-title":"Insulin resistance syndrome and polycystic ovary syndrome","volume":"9","author":"Nestler","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/j.mcna.2007.06.010_bib52","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2007.06.010_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 264 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib55","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2007.06.010_bib56","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycemia to impaired glucose tolerance of non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mcna.2007.06.010_bib57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/09513598909152304","article-title":"Lack of predictive value of HbA1C for impaired glucose tolerance in polycystic ovary syndrome","volume":"3","author":"Golland","year":"1989","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.mcna.2007.06.010_bib58","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib59","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes mellitus","volume":"24","author":"Peppard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2007.06.010_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2265.2000.00884.x","article-title":"The prevalence of polycystic ovaries in women with type 2 diabetes mellitus","volume":"52","author":"Conn","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mcna.2007.06.010_bib61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0996-949b","article-title":"Gender differences in plasma leptin concentrations","volume":"2","author":"Havel","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.mcna.2007.06.010_bib63","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/jama.283.12.1567-JLT0322-14-1","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"283","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.06.010_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mcna.2007.06.010_bib65","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","article-title":"Adipocytokines: leptin\u2014the classical, resistin\u2014the controversial, adiponectin\u2014the promising, and more to come","volume":"19","author":"Koerner","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/jc.2003-031163","article-title":"Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population","volume":"89","author":"Yamamoto","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1462-8902.2004.00334.x","article-title":"Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?","volume":"6","author":"Rea","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib68","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/humrep\/del146","article-title":"Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study","volume":"21","author":"Escobar-Morreale","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mcna.2007.06.010_bib69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.1.02207","article-title":"Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls","volume":"155","author":"Glintborg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mcna.2007.06.010_bib70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.1.01868","article-title":"Evidence for altered adipocyte function in polycystic ovary syndrome","volume":"152","author":"Carmina","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mcna.2007.06.010_bib71","first-page":"553","article-title":"Gherlin expression in women with polycystic ovary syndrome: a preliminary study","volume":"26","author":"Skommer","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.mcna.2007.06.010_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.05.069","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome","volume":"87","author":"Neveu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mcna.2007.06.010_bib73","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1701-2163(16)32202-2","article-title":"Use of metformin for ovulation induction in women who have polycystic ovary syndrome with or without evidence of insulin resistance","volume":"28","author":"Liu","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.mcna.2007.06.010_bib74","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fertnstert.2006.06.014","article-title":"Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review","volume":"86","author":"Siebert","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mcna.2007.06.010_bib75","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2006.03.009","article-title":"Pregnancy complications in PCOS","volume":"20","author":"Homburg","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib76","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/09513590601010508","article-title":"Metformin reduces abortion in pregnant women with polycystic ovary syndrome","volume":"22","author":"Khattab","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.mcna.2007.06.010_bib77","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2007.06.010_bib78","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mcna.2007.06.010_bib79","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0889-8545(05)70168-6","article-title":"Oral contraceptives: risks","volume":"27","author":"Shulman","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.mcna.2007.06.010_bib80","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0029-7844(02)02725-4","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712507000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712507000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T08:41:41Z","timestamp":1556959301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712507000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0025712507000831"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2007.06.010","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}